1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
fax: 507-284-0762
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Autoimmune, Cholestatic and Biliary Disease
You have full text access to this OnlineOpen article
Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: Evidence for a gene–gene interaction†
Article first published online: 15 MAR 2010
DOI: 10.1002/hep.23667
Copyright © 2010 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Juran, B. D., Atkinson, E. J., Larson, J. J., Schlicht, E. M., Liu, X., Jenny Heathcote, E., Hirschfield, G. M., Siminovitch, K. A. and Lazaridis, K. N. (2010), Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: Evidence for a gene–gene interaction. Hepatology, 52: 223–229. doi: 10.1002/hep.23667
- †
Potential conflict of interest: Nothing to report.
- ‡
fax: 507-284-0762
Publication History
- Issue published online: 23 JUN 2010
- Article first published online: 15 MAR 2010
- Manuscript Accepted: 7 MAR 2010
- Manuscript Received: 18 DEC 2009
Funded by
- NIH. Grant Numbers: K23 DK68290, RO3 DK078527, RO1 DK80670
- American Gastroenterological Association (AGA)
- Foundation for Digestive Health and Nutrition (FDHN)
- American Liver Foundation
- Palumbo Charitable Trust
- Mayo Clinic College of Medicine
References
- 1, . Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273.
- 2
- 3, . Antimitochondrial antibody-negative primary biliary cirrhosis. Gastroenterol Clin North Am 2008; 37: 479-484, viii.
- 4, . Applying genomics to the study of complex disease. Semin Liver Dis 2007; 27: 3-12.
- 5, . Autoimmunity risk alleles in costimulation pathways. Immunol Rev 2009; 229: 322-336.
- 6, , , , , , et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1: 405-413.
- 7, , . CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 2541-2550.
- 8, , , , , . CTLA-4-mediated inhibition of early events of T cell proliferation. J Immunol 1999; 162: 5813-5820.
- 9, . CTLA-4 and tolerance: the biochemical point of view. Immunol Res 2003; 28: 241-253.
- 10, , , , , , et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995; 270: 985-988.
- 11, , , , , . Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541-547.
- 12, , . CTLA4 gene polymorphism and autoimmunity. Immunol Rev 2005; 204: 102-115.
- 13, , , , , , et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000; 32: 538-541.
- 14, , , , , , et al. [Genetic association between interleukins gene polymorphisms with primary biliary cirrhosis in Chinese population]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2004; 26: 505-509.
- 15
- 16, , , , , , et al. Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007; 5: 755-760.
- 17, , , , , , et al. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease. Eur J Gastroenterol Hepatol 2007; 19: 947-951.
- 18, , , , , . Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. HEPATOLOGY 2008; 47: 563-570.
- 19, , , , , , et al. Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol 2008; 49: 1038-1045.
- 20, , , , . Primary biliary cirrhosis is associated with a genetic variant in the 3′ flanking region of the CTLA4 gene. Gastroenterology 2008; 135: 1200-1206.
- 21, , , , , , et al. CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum 2009; 60: 931-937.
- 22, , , , . CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2001; 2: 145-152.
- 23, , , , , , et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002; 54: 1-8.
- 24, , , , . A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 2002; 277: 46478-46486.
- 25, , , , , , et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
- 26, , , . Tumour necrosis factor alpha-308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 2009; 1792: 163-172.
- 27, , , , , , et al. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. J Hepatol 1999; 30: 232-236.
- 28, , , , , , et al. The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis. J Hepatol 1999; 30: 826-829.
- 29, , , , , . Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. J Hepatol 1999; 31: 242-247.
- 30, , , , . Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997; 94: 3195-3199.
- 31, , , , , , et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-406.
- 32, , , , , , et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999; 282: 561-568.
- 33, , , , , , et al. Increased prevalence of AMA in first-degree relatives of patients with primary biliary cirrhosis. HEPATOLOGY 2007; 46: 785-792.
- 34, , , , , , et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009; 360: 2544-2555.
- 35, . Genetics of autoimmune diseases: disorders of immune homeostasis. Nat Rev Genet 2006; 7: 917-928.
- 36, . Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008; 17: R116-121.
- 37, , , , , , et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008; 322: 271-275.
- 38, , , , , , et al. Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity. J Immunol 2009; 182: 274-282.
- 39, , , , , , et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. HEPATOLOGY 2006; 43: 729-737.
- 40, , , , , , et al. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 2001; 409: 97-101.
- 41, , , , , , et al. ICOS is essential for effective T-helper-cell responses. Nature 2001; 409: 105-109.